360 related articles for article (PubMed ID: 19295645)
21. Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study.
Larsson PG; Stray-Pedersen B; Ryttig KR; Larsen S
BMC Womens Health; 2008 Jan; 8():3. PubMed ID: 18197974
[TBL] [Abstract][Full Text] [Related]
22. [Efficacy of combined 5-nitroimidazole and probiotic therapy of bacterial vaginosis: randomized open trial].
Kovachev S; Vatcheva-Dobrevski R
Akush Ginekol (Sofiia); 2013; 52(3):19-26. PubMed ID: 24283058
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of oral intake of
Sharpe M; Shah V; Freire-Lizama T; Cates EC; McGrath K; David I; Cowan S; Letkeman J; Stewart-Wilson E
J Matern Fetal Neonatal Med; 2021 Jun; 34(11):1814-1821. PubMed ID: 31362572
[TBL] [Abstract][Full Text] [Related]
24. Effect of Lactobacillus challenge on Gardnerella vaginalis biofilms.
Saunders S; Bocking A; Challis J; Reid G
Colloids Surf B Biointerfaces; 2007 Apr; 55(2):138-42. PubMed ID: 17234391
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of orally applied probiotic capsules for bacterial vaginosis and other vaginal infections: a double-blind, randomized, placebo-controlled study.
Vujic G; Jajac Knez A; Despot Stefanovic V; Kuzmic Vrbanovic V
Eur J Obstet Gynecol Reprod Biol; 2013 May; 168(1):75-9. PubMed ID: 23395559
[TBL] [Abstract][Full Text] [Related]
26. Effect of a yoghurt drink containing Lactobacillus strains on bacterial vaginosis in women - a double-blind, randomised, controlled clinical pilot trial.
Laue C; Papazova E; Liesegang A; Pannenbeckers A; Arendarski P; Linnerth B; Domig KJ; Kneifel W; Petricevic L; Schrezenmeir J
Benef Microbes; 2018 Jan; 9(1):35-50. PubMed ID: 29065710
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness of the two microorganisms Lactobacillus fermentum LF15 and Lactobacillus plantarum LP01, formulated in slow-release vaginal tablets, in women affected by bacterial vaginosis: a pilot study.
Vicariotto F; Mogna L; Del Piano M
J Clin Gastroenterol; 2014; 48 Suppl 1():S106-12. PubMed ID: 25291116
[TBL] [Abstract][Full Text] [Related]
28. Evidence-based mixture containing Lactobacillus strains and lactoferrin to prevent recurrent bacterial vaginosis: a double blind, placebo controlled, randomised clinical trial.
Russo R; Karadja E; De Seta F
Benef Microbes; 2019 Feb; 10(1):19-26. PubMed ID: 30525953
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of vaginal probiotic capsules for recurrent bacterial vaginosis: a double-blind, randomized, placebo-controlled study.
Ya W; Reifer C; Miller LE
Am J Obstet Gynecol; 2010 Aug; 203(2):120.e1-6. PubMed ID: 20659602
[TBL] [Abstract][Full Text] [Related]
30. Effect of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 on the ability of Candida albicans to infect cells and induce inflammation.
Martinez RC; Seney SL; Summers KL; Nomizo A; De Martinis EC; Reid G
Microbiol Immunol; 2009 Sep; 53(9):487-95. PubMed ID: 19703242
[TBL] [Abstract][Full Text] [Related]
31. Effect of probiotics on vaginal health in pregnancy. EFFPRO, a randomized controlled trial.
Gille C; Böer B; Marschal M; Urschitz MS; Heinecke V; Hund V; Speidel S; Tarnow I; Mylonas I; Franz A; Engel C; Poets CF
Am J Obstet Gynecol; 2016 Nov; 215(5):608.e1-608.e7. PubMed ID: 27342046
[TBL] [Abstract][Full Text] [Related]
32. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora.
Reid G; Beuerman D; Heinemann C; Bruce AW
FEMS Immunol Med Microbiol; 2001 Dec; 32(1):37-41. PubMed ID: 11750220
[TBL] [Abstract][Full Text] [Related]
33. Nucleic acid-based diagnosis of bacterial vaginosis and improved management using probiotic lactobacilli.
Reid G; Burton J; Hammond JA; Bruce AW
J Med Food; 2004; 7(2):223-8. PubMed ID: 15298771
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of a vaginal medicinal product containing three strains of probiotic bacteria: a multicenter, randomized, double-blind, and placebo-controlled trial.
Tomusiak A; Strus M; Heczko PB; Adamski P; Stefański G; Mikołajczyk-Cichońska A; Suda-Szczurek M
Drug Des Devel Ther; 2015; 9():5345-54. PubMed ID: 26451088
[TBL] [Abstract][Full Text] [Related]
35. [Probiotic monotherapy of bacterial vaginosis: a open, randomized trial].
Kovachev S; Dobrevski-Vacheva R
Akush Ginekol (Sofiia); 2013; 52 Suppl 1():36-42. PubMed ID: 24294744
[TBL] [Abstract][Full Text] [Related]
36. Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection.
Pendharkar S; Brandsborg E; Hammarström L; Marcotte H; Larsson PG
BMC Infect Dis; 2015 Jul; 15():255. PubMed ID: 26137971
[TBL] [Abstract][Full Text] [Related]
37. Probiotic interference of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 with the opportunistic fungal pathogen Candida albicans.
Köhler GA; Assefa S; Reid G
Infect Dis Obstet Gynecol; 2012; 2012():636474. PubMed ID: 22811591
[TBL] [Abstract][Full Text] [Related]
38. Oral Intake of Lactobacilli Can Be Helpful in Symptomatic Bacterial Vaginosis: A Randomized Clinical Study.
Reznichenko H; Henyk N; Maliuk V; Khyzhnyak T; Tynna Y; Filipiuk I; Veresniuk N; Zubrytska L; Quintens J; Richir K; Gerasymov S
J Low Genit Tract Dis; 2020 Jul; 24(3):284-289. PubMed ID: 32091443
[TBL] [Abstract][Full Text] [Related]
39. [Effect of Lactobacillus casei var rhamnosus (Gynophilus) in restoring the vaginal flora by female patients with bacterial vaginosis--randomized, open clinical trial].
Kovachev S; Dobrevski-Vacheva R
Akush Ginekol (Sofiia); 2013; 52 Suppl 1():48-53. PubMed ID: 24294746
[TBL] [Abstract][Full Text] [Related]
40. Characterization and complete genome sequences of L. rhamnosus DSM 14870 and L. gasseri DSM 14869 contained in the EcoVag
Marcotte H; Krogh Andersen K; Lin Y; Zuo F; Zeng Z; Larsson PG; Brandsborg E; Brønstad G; Hammarström L
Microbiol Res; 2017 Dec; 205():88-98. PubMed ID: 28942850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
